- CNO Financial’s book value per share for Q1 is $25.33, exceeding both the previous year’s $21.81 and the estimated $24.75.
- The adjusted operating earnings per share (EPS) for Q1 is 79 cents, up from 52 cents in the previous year, meeting the estimates.
- The company has reaffirmed its full-year 2025 and three-year return on equity (ROE) guidance.
- Analyst recommendations include 1 buy, 5 holds, and 1 sell.
A look at Cno Financial Group Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
According to Smartkarma Smart Scores, CNO Financial Group is positioned for a positive long-term outlook. The company has received solid scores across various key factors, reflecting a balanced performance in terms of value, dividend, growth, resilience, and particularly momentum. CNO Financial Group, Inc. focuses on providing insurance products and services to American families and seniors, catering to the needs of middle-income individuals and senior citizens.
With a strong momentum score of 5, CNO Financial Group is showing significant positive market momentum. This, combined with consistent scores in other areas such as value, dividend, growth, and resilience, suggests a stable and potentially lucrative future for the company. Investors may find CNO Financial Group’s overall outlook promising, benefiting from its strong momentum and diversified offerings in the insurance sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
